Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Apr 23, 2025 | Returns since inception | ET Money Rank | VRO Ratings |
---|---|---|---|
₹9.7+0.21% 1 day change | -2.81% | N.A. |
VRO rating | N.A. |
Expense ratio | 0.66% as on Mar 31, 2025 |
Exit load | 0.5% Exit load of 0.50%, if redeemed within 90 days.! |
AUM (Fund size) | ₹104 Crs |
Lock-in | No Lockin |
Age | 5 m since Nov 19, 2024 |
Benchmark | BSE Healthcare TRI |
Min. investment | SIP ₹1000 & Lump. ₹5000 |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, pay tax of 12.5% on returns of ₹1.25 lakh+ in a financial year |
Period | This fund | Category average |
---|---|---|
1 month | 1.46% | 0.8% |
3 months | 1.25% | 0.61% |
Large Cap 34.01787%
Mid Cap 29.085375000000003%
Small Cap 33.03714%
Other Cap 0.00961500000000492%
Healthcare 86.54000000000002%
Services 4.6899999999999995%
Insurance 2.82%
Chemicals 2.1%
Bifurcation by Credit Quality is not available for this fund
Others 3.45%
CBLO 3.45%
Net Receivables 0.39999999%
Others 0.4%
Fund name | ETM Rank | AUM (in Crs.) | Fund age | Expense ratio |
---|---|---|---|---|
PGIM India Healthcare Fund | N.A. | ₹104 Crs | 5 m | 0.66% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | ₹4,915 Crs | 6 yrs 9 m | 1.18% |
SBI Healthcare Opportunities Fund | N.A. | ₹3,611 Crs | 12 yrs 3 m | 0.9% |
DSP Healthcare Fund | N.A. | ₹3,019 Crs | 6 yrs 5 m | 0.63% |
Tata India Pharma & HealthCare Fund | N.A. | ₹1,184 Crs | 9 yrs 4 m | 0.72% |
Mirae Asset Healthcare Fund | N.A. | ₹2,667 Crs | 6 yrs 10 m | 0.61% |
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
PGIM India Healthcare Fund | 1.46% | N.A. | N.A. | N.A. | N.A. | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 1.25% | -0.91% | 25.04% | 25.89% | 26.38% | 15.1% |
SBI Healthcare Opportunities Fund | 0.06% | 2.93% | 23.15% | 25.24% | 25.94% | 13.32% |
DSP Healthcare Fund | -1.44% | -5.28% | 18.69% | 22.05% | 26.08% | 15.24% |
Tata India Pharma & HealthCare Fund | 1.88% | -1.7% | 21.43% | 22.65% | 23.83% | 13.09% |
Mirae Asset Healthcare Fund | 0.52% | -1.7% | 22.46% | 20.85% | 24.59% | 15.25% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
PGIM India Healthcare Fund | N.A. | N.A. | N.A. | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 16.26 | 0.93 | 1.01 | 1.61 |
SBI Healthcare Opportunities Fund | 14.93 | 0.85 | 1.12 | 1.65 |
DSP Healthcare Fund | 15.95 | 0.87 | 0.91 | 1.56 |
Tata India Pharma & HealthCare Fund | 16.85 | 0.96 | 0.82 | 1.36 |
Mirae Asset Healthcare Fund | 17.14 | 0.98 | 0.77 | 1.27 |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
Fund AUM | ₹104 Crs as on Mar 31, 2025 |
Scheme document | View Scheme Document |
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
No. of schemes | 24 view all schemes |
Total AUM | ₹24,165 Crs as on Mar 31, 2025 |
Address | 7th Floor, Radhe Empire, Chandavarkar Road Borivali (W), Mumbai Mumbai, 400092 |
Phone | +91 22 6159 5441 / 42 |
Fund name | ETM Rank | AUM (in Crs.) | 1Y | 5Y |
---|---|---|---|---|
PGIM India Midcap Opportunities Fund | N.A. | ₹10,302 Crs | 11.53% | 32.92% |
PGIM India Flexi Cap Fund | N.A. | ₹5,967 Crs | 10.21% | 26.86% |
PGIM India ELSS Tax Saver Fund | N.A. | ₹741 Crs | 12.46% | 25.73% |
PGIM India Large Cap Fund | N.A. | ₹569 Crs | 8.37% | 20.71% |
PGIM India Global Equity Opportunities Fund | N.A. | ₹1,251 Crs | -1.1% | 12.62% |
PGIM India Small Cap Fund | N.A. | ₹1,376 Crs | 6.97% | N.A. |
The current Net Asset Value (NAV) of the PGIM India Healthcare Fund - Direct Growth plan is approximately ₹9.7 as of Apr 23, 2025.
The PGIM India Healthcare Fund - Direct Growth has an expense ratio of 0.66%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.
The PGIM India Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately ₹104 Crs crore as of Mar 31, 2025.
The PGIM India Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Sun Pharmaceutical Industries Ltd. | 12.76% |
Divi's Laboratories Ltd. | 7.59% |
Max Healthcare Institute Ltd. | 7.15% |
Dr. Reddy's Laboratories Ltd. | 6.03% |
Mankind Pharma Ltd. | 4.9% |
Aster DM Healthcare Ltd. | 4.73% |
Torrent Pharmaceuticals Ltd. | 3.91% |
Krishna Institute of Medical Sciences Ltd | 3.6% |
Abbott India Ltd. | 3.5% |
Ajanta Pharma Ltd. | 3.33% |
The PGIM India Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 86.54000000000002% |
Services | 4.6899999999999995% |
Insurance | 2.82% |
Chemicals | 2.1% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. It is just a matter of a few minutes. Here's how:
For the Desktop Version:
For the Mobile Version:
All set! Your investment in PGIM India Healthcare Fund is complete.
Redeeming your investments in PGIM India Healthcare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in PGIM India Healthcare Fund from anywhere else, you can go to the fund house website and put a request through it.